Lau DCW, Erichsen L, Francisco AM et al (2021) Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
These frequently included both semaglutide and tirzepatide for diabetologists and endocrinologists, while for cardiologists, semaglutide was heavily dominant
This approach involves finding the minimal effective dose that sustains weight loss, typically between 0.5mg and 1.7mg per week, depending on individual response
A multivitamin containing these dietary supplements may help to improve cognition and concentration
Maybe a particular product combination consistently causes problems